Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
2-tert-Butyl-1,4-benzoquinone
Cat. No.:
0225LY-1441
Appearance:
Solid
Purity:
≥97%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
2-tert-Butyl-1,4-benzoquinone is a metabolite of BHA that facilitates Nrf2 activation by S-arylating its negative regulator, Keap1, within RAW264.7 cells.
Synonym:
2-tert-Butyl-1,4-benzoquinone; 3602-55-9; tert-Butylquinone; 2-tert-butylcyclohexa-2,5-diene-1,4-dione; 2-tert-Butyl-p-benzoquinone; tert-Butyl-p-benzoquinone; tert-Butylbenzoquinone; tert-Butyl-1,4-benzoquinone; 2-tert-Butyl-p-quinone; 2-tert-Butyl-4-quinone; 2-tert-Butyl quinone; 2,5-Cyclohexadiene-1,4-dione, 2-(1,1-dimethylethyl)-; 2-(1,1-Dimethylethyl)-2,5-cyclohexadiene-1,4-dione
CAS No.:
3602-55-9
Compound CID:
19211
Formula:
C10H12O2
Formula Weight:
164.2
Specification
Relative Density:
1.092 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
2-tert-Butyl-1,4-benzoquinone can be used in toxicology research to study the mechanisms of quinone-induced oxidative stress and cellular damage.
Library Information
Target:
Nrf2
Receptor:
Transcription factor
Pathways:
Oxidative stress; Immunology/Inflammation; Chromatin/Epigenetic
Plate Number:
AOCL-19
Plate Location:
e4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
60 mg/mL; 365.41 mM
